Intrinsiqq
Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc. Insider Trading

HOWL

Compare
Last 12 months

Insiders sold $2.15M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Jan 2023.

Net open-market
−$2.15M
0 buys · 25 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
Jan 2023
Jan 6, 2023

Get an email when HOWL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 6 – 710b5-1 plan
    Luke Evnin
    Director · sold 143,199 at avg $0.31
    45K
    100% of stake
  • Jun 2910b5-1 plan
    Luke Evnin
    Director · sold 157,084 at $0.30
    47K
    52% of stake
  • Jun 17No plan
    RA Capital Management, L.p.
    Large holder · sold 416,911 at avg $0.35
    146K
    58% of stake
  • Jun 12 – 16No plan
    RA Capital Management, L.p.
    Large holder · sold 448,836 at avg $0.39
    174K
    58% of stake
  • Jun 9 – 11No plan
    Peter Kolchinsky
    Large holder · sold 678,226 at avg $0.37
    254K
    65% of stake
  • Jun 910b5-1 plan
    Luke Evnin
    Director · sold 76,928 at $0.37
    28K
    20% of stake
  • Jun 4 – 810b5-1 plan
    Luke Evnin
    Director · sold 105,565 at avg $0.41
    43K
    22% of stake
  • Jun 1 – 310b5-1 plan
    Luke Evnin
    Director · sold 139,803 at avg $0.46
    64K
    22% of stake
  • May 27 – 2910b5-1 plan
    Luke Evnin
    Director · sold 141,106 at avg $0.47
    66K
    18% of stake
  • May 21 – 2610b5-1 plan
    Luke Evnin
    Director · sold 191,762 at avg $0.45
    87K
    20% of stake
  • May 18 – 2010b5-1 plan
    Luke Evnin
    Director · sold 171,049 at avg $0.45
    76K
    15% of stake
  • May 1310b5-1 plan
    Luke Evnin
    Director · sold 44,679 at $0.54
    24K
    3.8% of stake
  • May 8 – 12No plan
    RA Capital Management, L.p.
    Large holder · sold 565,167 at avg $0.69
    391K
    58% of stake
  • May 8 – 1210b5-1 plan
    Luke Evnin
    Director · sold 407,574 at avg $0.69
    280K
    26% of stake
  • May 5 – 710b5-1 plan
    Luke Evnin
    Director · sold 100,581 at avg $0.64
    64K
    6.0% of stake
  • Apr 30 – May 410b5-1 plan
    Luke Evnin
    Director · sold 274,619 at avg $0.72
    198K
    14% of stake
  • Apr 27 – 2910b5-1 plan
    Luke Evnin
    Director · sold 205,911 at avg $0.75
    155K
    9.5% of stake
  • Jan 1610b5-1 plan
    Luke Evnin
    Director · sold 38,782 at $0.54
    21K
    1.8% of stake
  • Jan 13 – 1510b5-1 plan
    Luke Evnin
    Director · sold 111,227 at avg $0.56
    62K
    4.8% of stake
  • Jan 8 – 1210b5-1 plan
    Luke Evnin
    Director · sold 91,374 at avg $0.59
    54K
    3.8% of stake
  • Jan 5 – 710b5-1 plan
    Luke Evnin
    Director · sold 71,054 at avg $0.65
    46K
    2.9% of stake
  • Dec 30, 2025 – Jan 210b5-1 plan
    Luke Evnin
    Director · sold 78,377 at avg $0.62
    48K
    3.1% of stake
  • Dec 22, 2025 – Dec 29, 202510b5-1 plan
    Luke Evnin
    Director · sold 291,283 at avg $0.64
    185K
    10% of stake
  • Dec 15, 2025 – Dec 17, 202510b5-1 plan
    Luke Evnin
    Director · sold 48,171 at avg $1.08
    52K
    1.7% of stake
  • Dec 10, 2025 – Dec 12, 202510b5-1 plan
    Luke Evnin
    Director · sold 82,971 at avg $1.07
    89K
    2.8% of stake
  • Dec 5, 2025 – Dec 9, 202510b5-1 plan
    Luke Evnin
    Director · sold 95,179 at avg $1.00
    95K
    3.1% of stake
  • Dec 2, 2025 – Dec 4, 202510b5-1 plan
    MPM Bioventures 2014 (b), L.p.
    Large holder · sold 199,732 at avg $0.92
    183K
    4.0% of stake
  • Dec 2, 2025 – Dec 4, 202510b5-1 plan
    MPM Bioimpact LLC
    Large holder · sold 199,732 at avg $0.92
    183K
    4.0% of stake
  • Dec 2, 2025 – Dec 4, 202510b5-1 plan
    Luke Evnin
    Director · sold 128,185 at avg $0.92
    118K
    4.0% of stake
  • Nov 26, 2025 – Dec 1, 202510b5-1 plan
    MPM Asset Management Investors Bv2014 LLC
    Large holder · sold 141,927 at avg $0.96
    137K
    2.8% of stake
  • Nov 26, 2025 – Dec 1, 202510b5-1 plan
    UBS Oncology Impact Fund L.p.
    Large holder · sold 141,927 at avg $0.96
    137K
    2.8% of stake
  • Nov 26, 2025 – Dec 1, 202510b5-1 plan
    Luke Evnin
    Director · sold 91,088 at avg $0.96
    88K
    2.8% of stake
  • Nov 21, 2025 – Nov 25, 202510b5-1 plan
    MPM Bioventures 2014 GP LLC
    Large holder · sold 195,666 at avg $0.92
    180K
    3.7% of stake
  • Nov 21, 2025 – Nov 25, 202510b5-1 plan
    MPM Oncology Innovations Fund GP LLC
    Large holder · sold 195,666 at avg $0.92
    180K
    3.7% of stake
  • Nov 21, 2025 – Nov 25, 202510b5-1 plan
    Luke Evnin
    Director · sold 125,576 at avg $0.92
    115K
    3.7% of stake
  • Nov 18, 2025 – Nov 20, 202510b5-1 plan
    MPM Bioventures 2014 LLC
    Large holder · sold 160,103 at avg $0.92
    148K
    2.9% of stake
  • Nov 18, 2025 – Nov 20, 202510b5-1 plan
    MPM Oncology Innovations Fund GP LLC
    Large holder · sold 160,103 at avg $0.92
    148K
    2.9% of stake
  • Nov 18, 2025 – Nov 20, 202510b5-1 plan
    Luke Evnin
    Director · sold 102,753 at avg $0.92
    95K
    2.9% of stake
  • Nov 13, 2025 – Nov 17, 202510b5-1 plan
    MPM Bioventures 2014 LLC
    Large holder · sold 209,652 at avg $0.96
    201K
    3.7% of stake
  • Nov 13, 2025 – Nov 17, 202510b5-1 plan
    MPM Oncology Innovations Fund GP LLC
    Large holder · sold 209,652 at avg $0.96
    201K
    3.7% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HOWL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with HOWL

CompareIntrinsic value
KTTAPasithea Therapeutics Corp.
$0.48-0.48%40
TPSTTempest Therapeutics Inc.
$0.29-5.36%0
PCSAProcessa Pharmaceuticals Inc.
$1.56-7.69%10
CPIXCumberland Pharmaceuticals Inc.
$5.84-7.30%20
GRIGri Bio Inc.
$1.12+0.00%20
PSTVPlus Therapeutics Inc
No recent price20
EVFMEvofem Biosciences Inc.
$1.00+0.00%15
MBRXMoleculin Biotech Inc.
$7.74-2.40%20

Spot a number that looks wrong? Check it in HOWL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HOWL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.